Literature DB >> 8639161

Intracellular trafficking of lysosomal membrane proteins.

W Hunziker1, H J Geuze.   

Abstract

Lysosomes are the site of degradation of obsolete intracellular material during autophagy and of extracellular macromolecules following endocytosis and phagocytosis. The membrane of lysosomes and late endosomes is enriched in highly glycosylated transmembrane proteins of largely unknown function. Significant progress has been made in recent years towards elucidating the pathways by which these lysosomal membrane proteins are delivered to late endosomes and lysosomes. While some lysosomal membrane proteins follow the constitutive secretory pathway and reach lysosomes indirectly via the cell surface and endocytosis, others exit the trans-Golgi network in clathrin-coated vesicles for direct delivery to endosomes and lysosomes. Sorting from the Golgi or the plasma membrane into the endosomal system is mediated by signals encoded by the short cytosolic domain of these proteins. This review will discuss the role of lysosomal membrane proteins in the biogenesis of the late endosomal and lysosomal membranes, with particular emphasis on the structural features and molecular mechanisms underlying the intracellular trafficking of these proteins.

Mesh:

Substances:

Year:  1996        PMID: 8639161     DOI: 10.1002/bies.950180508

Source DB:  PubMed          Journal:  Bioessays        ISSN: 0265-9247            Impact factor:   4.345


  81 in total

1.  Delivery of a secreted soluble protein to the vacuole via a membrane anchor.

Authors:  F Barrieu; M J Chrispeels
Journal:  Plant Physiol       Date:  1999-08       Impact factor: 8.340

2.  The tetraspanin CD63/lamp3 cycles between endocytic and secretory compartments in human endothelial cells.

Authors:  T Kobayashi; U M Vischer; C Rosnoblet; C Lebrand; M Lindsay; R G Parton; E K Kruithof; J Gruenberg
Journal:  Mol Biol Cell       Date:  2000-05       Impact factor: 4.138

3.  Competing sorting signals guide endolyn along a novel route to lysosomes in MDCK cells.

Authors:  G Ihrke; J R Bruns; J P Luzio; O A Weisz
Journal:  EMBO J       Date:  2001-11-15       Impact factor: 11.598

4.  Redundancy, antiredundancy, and the robustness of genomes.

Authors:  David C Krakauer; Joshua B Plotkin
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-29       Impact factor: 11.205

5.  Lysosome-associated protein transmembrane 4 alpha (LAPTM4 alpha) requires two tandemly arranged tyrosine-based signals for sorting to lysosomes.

Authors:  Douglas L Hogue; Colin Nash; Victor Ling; Tom C Hobman
Journal:  Biochem J       Date:  2002-08-01       Impact factor: 3.857

6.  Role of adaptor complex AP-3 in targeting wild-type and mutated CD63 to lysosomes.

Authors:  Brian A Rous; Barbara J Reaves; Gudrun Ihrke; John A G Briggs; Sally R Gray; David J Stephens; George Banting; J Paul Luzio
Journal:  Mol Biol Cell       Date:  2002-03       Impact factor: 4.138

7.  Proteasome inhibitors block a late step in lysosomal transport of selected membrane but not soluble proteins.

Authors:  P van Kerkhof; C M Alves dos Santos; M Sachse; J Klumperman; G Bu; G J Strous
Journal:  Mol Biol Cell       Date:  2001-08       Impact factor: 4.138

8.  Characterisation of near-full length genome sequences of three South African human immunodeficiency virus type 1 subtype C isolates.

Authors:  Gillian M Hunt; Maria A Papathanasopoulos; Glenda E Gray; Caroline T Tiemessen
Journal:  Virus Genes       Date:  2003-01       Impact factor: 2.332

9.  ARF1.GTP, tyrosine-based signals, and phosphatidylinositol 4,5-bisphosphate constitute a minimal machinery to recruit the AP-1 clathrin adaptor to membranes.

Authors:  Pascal Crottet; Daniel M Meyer; Jack Rohrer; Martin Spiess
Journal:  Mol Biol Cell       Date:  2002-10       Impact factor: 4.138

10.  Trafficking of TrkA-green fluorescent protein chimerae during nerve growth factor-induced differentiation.

Authors:  Jérôme Jullien; Vincent Guili; Edmund A Derrington; Jean-Luc Darlix; Louis F Reichardt; Brian B Rudkin
Journal:  J Biol Chem       Date:  2002-11-15       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.